Objectives: To identify and characterize a novel cfr variant that recently emerged and confers multidrug resistance in Campylobacter, a major foodborne pathogen.
Introduction
The cfr gene, encoding an rRNA methyltransferase, confers resistance to five chemically unrelated antimicrobial classes including phenicols, lincosamides, oxazolidinones, pleuromutilins and streptogramin A (known as the PhLOPS A phenotype). 1 Of particular concern is the resistance to the oxazolidinone class (e.g. linezolid), which is used as the last resort for treating MDR Gram-positive bacterial infections in humans. 2 Since its first discovery in a bovine Staphylococcus sciuri isolate in 2000, the cfr gene has been detected in a variety of Gram-positive and -negative bacteria. [3] [4] [5] [6] [7] The cfr gene was often found on transferable plasmids with additional antibiotic resistance genes, which further facilitates its dissemination and emergence in different bacterial species and genera. [8] [9] [10] [11] A cfr-like gene, cfr(B), has recently been discovered in mobile genetic elements in both Peptoclostridium difficile and Enterococcus faecium of human origin, conferring the same multidrug resistance phenotype and sharing 74.9% identity in amino acid (aa) sequences with the original Cfr. 12, 13 Thermophilic Campylobacter (including Campylobacter jejuni and Campylobacter coli) are major foodborne pathogens and leading bacterial causes of gastroenteritis in the USA and other countries. 14, 15 Campylobacter is commonly present in food-producing animals, and in addition to poultry, ruminants are important reservoirs for this pathogenic organism. 16 Ruminant Campylobacter can be transmitted to humans via contaminated milk and water, environmental contamination and direct contact with animals. [16] [17] [18] Antimicrobial resistance in Campylobacter, compromising the clinical treatment of campylobacteriosis, has become in recent years a major public health concern in both developed and developing counties. 14, [19] [20] [21] [22] Indeed, the 2013 CDC report classified drug-resistant Campylobacter as a serious antibiotic resistance threat in the USA (https://www.cdc.gov/drugresistance/threat-re port-2013/). Several mechanisms conferring resistance to clinically important antibiotics have been described in Campylobacter, including mutations in target genes, such as gyrA mutations to fluoroquinolones and 23S rRNA mutations to macrolides, 23, 24 V C The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com. multidrug efflux pump CmeABC extruding structurally diverse compounds and antimicrobials, 25 and horizontally acquired antibiotic resistance genes, such as tet(O) and aphA-3.
26
Recently, a ribosomal RNA methylase gene erm(B) conferring highlevel resistance to macrolide was identified in both C. jejuni and C. coli.
27,28
As a foodborne pathogen, Campylobacter is exposed to antimicrobials used for both food animal production and human medicine. In the USA, florfenicol is currently indicated for the treatment of bovine and swine respiratory disease, serving as a selection force for florfenicol-resistant organisms in food-producing animals. Although the cfr gene has been identified in both Grampositive and -negative organisms, it has not been reported in foodborne pathogens including Campylobacter. In this study, a novel plasmid borne cfr-like gene, designated cfr(C) (the nomenclature was approved by the Nomenclature Center for MLS Genes curated by Marilyn C. Roberts at University of Washington), was identified in MDR C. coli isolates of cattle origin. The cfr(C) gene was found to confer transferable resistance to oxazolidinones (linezolid) and phenicols (chloramphenicol and florfenicol) as well as lincosamides and pleuromutilins (Campylobacter is naturally resistant to streptogramins) in both C. jejuni and C. coli. To the best of our knowledge, this is the first report of a novel cfr-like gene in a foodborne pathogen.
Materials and methods

Bacterial isolates and detection of florfenicol resistance genes
During a surveillance study of the antimicrobial susceptibility of Campylobacter isolates from feedlot cattle farms in five different US states, a large number (2220) of Campylobacter isolates were obtained from faecal samples. These isolates were identified as either C. jejuni or C. coli by species-specific PCR as described previously. 29, 30 Tx40, a C. coli isolate from the collection, exhibited elevated MICs of florfenicol and chloramphenicol. To determine whether Tx40 harboured known florfenicol resistance genes (cfr, florR, fexA, fexB) or the G2073A mutation in 23S rRNA, PCR reactions were conducted using primers specific for the target genes or mutations as described previously. 4, [31] [32] [33] [34] For screening the distribution of cfr(C) in different Campylobacter isolates, PCR was designed to detect an internal fragment of the cfr(C) gene among C. jejuni (n " 1886) and C. coli (n " 344) isolates from feedlot cattle using primers cfr(C)-F (5 0 -GGTGAAACTGTTGTGGAGAT-3 0 ) and
. The expected size of PCR product was 722 bp. All isolates carrying the gene of interest were investigated for their chloramphenicol susceptibility, PFGE patterns and MLST types.
Transfer of florfenicol resistance by conjugation C. jejuni JL272 is an erythromycin-resistant (Ery R ) derivative of NCTC 11168 and carries an A2074G mutation in the 23S rRNA gene, conferring a highlevel erythromycin resistance (MIC 1024 mg/L). 35 To determine if the florfenicol resistance in C. coli Tx40 was transferable between Campylobacter species, a conjugation experiment was performed as described before. 36 Briefly, the florfenicol-resistant C. coli Tx40 was used as the donor strain, and Ery R but florfenicol-susceptible C. jejuni JL272 was used as the recipient strain. Transconjugants were selected on Mueller-Hinton (MH) agar plates containing 4 mg/L florfenicol and 30 mg/L erythromycin. Conjugation without the donor strain served as a negative control. The transconjugants were analysed for antimicrobial susceptibility in comparison with the donor and recipient isolates.
S1 nuclease PFGE
To detect the presence and size of plasmid pTx40, the three Campylobacter strains, including C. coli Tx40, transconjugant JL272/pTx40 and C. jejuni JL272, were analysed by S1 nuclease PFGE as described previously. 37 Briefly, the agarose plugs containing Campylobacter isolates were digested with S1 nuclease (Sigma) in 200 lL of 50 mM NaCl, 30 mM sodium acetate (pH 4.5) and 5 mM ZnSO 4 at 37 C for 45 min. The digested and undigested plugs were embedded into 1% agarose gel. Electrophoresis was conducted for 18 h in 0.5% TBE buffer. Gels were stained with ethidium bromide and destained with distilled water. Gel images were taken with a digital imaging system. 38 
WGS and plasmid analysis
Genomic DNA of C. coli Tx40 and transconjugant JL272/pTx40 were purified using Wizard V R genomic DNA purification kit (Promega, Madison, WI, USA). The purified genomic DNA was submitted to the DNA facility of Iowa State University (USA) for library preparation using TruSeq DNA PCR-free library preparation kit. The WGS was carried out using the Illumina V R Miseq instrument. The generated reads were assembled de novo into contigs using the Velvet (v 1.2.10) and VelvetOptimiser (v 2.2.5). 39 Genome annotation was performed using the RAST server. 40 The contigs of transconjugant JL272/ pTx40 were aligned against the reference genome (NC_002163) of the recipient strain JL272 by using Mauve (v 2.3.1). [41] [42] [43] The additional contig in transconjugant JL272/pTx40 was identified as plasmid pTx40. The plasmid sequence was closed by regular PCR and DNA sequencing, and annotation was further confirmed using the BLAST program Blastn, Blastp (NCBI) and DNAPlotter software. 44 The draft genome sequences of C. coli Tx40 were aligned and then used for phylogenetic tree construction based on SNP alignment by Parsnp in the Harvest package. 45 The phylogenetic tree was visualized with FigTree (http://tree.bio.ed.ac.uk/software/figtree).
Cloning of cfr(C) into Escherichia coli and C. jejuni by transformation and conjugation
To determine the role of cfr(C) in conferring florfenicol resistance, a 1361 bp DNA fragment was amplified from C. coli Tx40 isolate using primer cfr(C)-
. This fragment includes the coding sequence of cfr(C) (1140 bp), as well as the 163 bp upstream sequence of the gene and 58 bp downstream sequence of the gene. The amplicon was digested with XbaI and EcoRI and ligated with an E. coli/C. jejuni shuttle plasmid pRY108 46 to construct plasmid pRY108-cfr(C). The pRY108-cfr(C) plasmid was then transformed into E. coli DH5a competent cells by chemical transformation. The E. coli transformants were selected from LB agar plates containing 30 mg/L kanamycin, and further confirmed for carrying plasmid pRY108-cfr(C) by PCR using the cfr(C) specific primers. Plasmid pRY108-cfr(C) in E. coli was transferred into the C. jejuni NCTC 11168 isolate by triparental conjugation as described previously. 47 Transconjugants were selected on MH agar plates containing 30 mg/L kanamycin and selective supplements (Oxoid, Cambridge, UK). The presence of cfr(C) gene in the C. jejuni transconjugant was confirmed by PCR and DNA sequencing of the cfr(C) gene.
Antimicrobial susceptibility testing
For antimicrobial susceptibility testing of Campylobacter isolates, the MICs of nine antibiotics were determined using Sensititre plates (Trek Diagnostic Systems, Thermo Fisher Scientific Inc., Cleveland, OH, USA) as recommended by the manufacturer. The nine antibiotics include azithromycin, ciprofloxacin, erythromycin, gentamicin, tetracycline, florfenicol, nalidixic acid, telithromycin and clindamycin. To investigate further if cfr(C) confers a PhLOPS A resistance Tang et al. phenotype in Campylobacter, the parent isolate C. coli Tx40, its transconjugants and transformants, and the recipient strain were analysed for susceptibility to chloramphenicol, florfenicol, linezolid, tedizolid, gentamicin and clindamycin using broth microdilution as recommended by CLSI. 48 C. jejuni ATCC 33560 was used as a quality control strain.
GenBank accession numbers
The draft genome sequence of Tx40 has been deposited in DDBJ/ENA/ GenBank under the accession no. MDCN00000000. The version described in this article is version MDCN01000000. The whole sequence of pTx40 has been deposited under the accession no. KX686749.
Results
Initial identification of a novel transferable florfenicol resistance determinant
During our surveillance study of Campylobacter from feedlot cattle, we noticed that a C. coli isolate, Tx40, was resistant to multiple classes of antibiotics including ciprofloxacin, clindamycin, florfenicol, nalidixic acid and tetracycline as analysed by the Sensititre plate MIC testing method (Table 1) . Notably, this isolate exhibited a florfenicol MIC of 32 mg/L, which is rarely reported in Campylobacter. To understand why Tx40 was highly resistant to florfenicol, we performed PCR analysis of known florfenicol resistance mechanisms in this isolate. However, neither the reported florfenicol resistance genes including cfr, florR, fexA, fexB, nor the G2073A mutation in 23S rRNA were detected in Tx40 (data not shown). Next, conjugation was carried out to determine the transferability of florfenicol resistance in Tx40. Interestingly, the resistance phenotype was transferable and the transconjugant, designated JL272/pTx40, exhibited 8-32-fold increase in the MICs of chloramphenicol and florfenicol compared with the recipient strain JL272 (Table 1) . S1 nuclease PFGE revealed the presence of a plasmid with a size of 48 kb in C. coli Tx40 and its transconjugant JL272/pTx40, but not in the recipient strain JL272 (Figure 1 ). These results strongly suggested that a previously undescribed florfenicol resistance gene was present on a conjugative plasmid, named pTx40, in C. coli Tx40.
Sequences of plasmid pTx40 and the novel gene cfr(C)
To identify the previously uncharacterized florfenicol resistance gene, the whole genome of C. coli Tx40 and its transconjugant JL272/pTx40 were sequenced. The draft genome of C. coli Tx40 is 1 718 047 bp in length, with a GC content of 31.3%. Annotation of the draft sequence indicated the presence of 1787 putative coding sequences on the chromosome and 37 detected tRNAs. Sequences analysis showed that C. coli Tx40 encodes many of the common virulence factors involved in adherence, invasions, motility, immune evasion and toxins in Campylobacter, such as CadF, MOMP, PEB1, CiaB, Flagella, LOS, N-linked glycosylation system, O-linked glycosylation system and CDT. The assembled draft genome of C. coli Tx40 is 99% identical to those of both C. coli strain cfr(C)-mediated multidrug resistance in Campylobacter JAC RM5611 and HC2-48 in the NCBI database (Figure 2a) , except for an additional putative prophage consisting of five extra contigs (32 kb in total). Both RM5611 and HC2-48 were isolated from cattle as indicated in the NCBI database.
We also assembled the genome of transconjugant JL272/ pTx40. To determine the sequence of the acquired plasmid pTx40, we aligned the contigs of transconjugant JL272/pTx40 to the genome of the recipient strain C. jejuni JL272, which is identical to C. jejuni NCTC 11168 except for the A2074G mutation in the 23S rRNA gene. 35 Interestingly, an additional contig of 48 144 bp was found in JL272/pTx40 and it was absent in the genome of the recipient strain C. jejuni JL272. The size of the contig is consistent with what we estimated by the S1 nuclease PFGE analysis (Figure 1) . Additionally, strain Tx40 contained the same contig as the one in transconjugant JL272/pTx40. Then a PCR reaction using a primer pair located at both ends of the 48 144 bp contig yielded an expected product, which confirmed the circular form of this fragment. Therefore, the additional contig in C. jejuni transconjugant JL272/pTx40 represents the full sequence of the conjugative plasmid pTx40, which was acquired from C. coli Tx40 isolate via conjugation.
Plasmid pTx40 was annotated to encode 47 ORFs, among which 25 ORFs encode hypothetical proteins, while the other 22 ORFs encode proteins with known functions, including genes related to plasmid replication (repA), antimicrobial resistance [tet(O), aphA-3], conjugative transfer (traC, trbL, traJ) and plasmid maintenance (cotH). Among these ORFs, there is a putative gene of 1140 bp encoding a 379 aa protein, showing high similarity to the sequences of the S-adenosylmethionine enzyme superfamily, which includes the Cfr protein. The N-terminal 352 aa were almost identical to the corresponding part of a ribosomal RNA large subunit methyltransferase N from both C. difficile F548 (GenBank accession no. WP_021434980) and C. difficile P1 (GenBank accession no. WP_021416053). Interestingly, the 379 aa putative protein only shows 55.1% or 54.9% identity to the original Cfr (GenBank accession no. CAC04525.1) from Staphylococcus sciuri 4 or the Tang et al.
recent reported Cfr(B) (GenBank accession no. AKV84429.1) from E. faecium (Figure 3) , 13 respectively. Therefore, we hypothesized that the 1140 bp putative gene, designated cfr(C), encodes a novel Cfr(C) protein, conferring multidrug resistance in Campylobacter.
Function of cfr(C) in conferring the PhLOPS A phenotype
To determine the function of cfr(C), its encoding sequence along with the promoter region was amplified from Tx40 and cloned into shuttle plasmid pRY108. 46 The construct pRY108-cfr(C) was successfully transferred into C. jejuni NCTC 11168 by triparental conjugation. The parent strain, recipient and transconjugant were assayed for their susceptibility to PhLOPS A antimicrobials. Owing to the intrinsic resistance of Campylobacter to streptogramin, the MIC of streptogramin was not determined, while the susceptibilities to other four antimicrobial classes (phenicols, lincosamides, oxazolidinones and pleuromutilins) were tested ( Table 1 ). The control strain, which was NCTC 11168 carrying an empty pRY108 plasmid, did not change the susceptibility to the tested antimicrobials. However, C. jejuni NCTC 11168 carrying pRY108-cfr(C) showed significantly elevated MICs of the tested antibiotics (Table 1) , including chloramphenicol (8-fold), florfenicol (16-fold), linezolid (16-fold), tiamulin (.128-fold) and clindamycin (.256-fold). The results clearly indicated that cfr(C) is functional in Campylobacter and encodes a novel Cfr(C) protein, contributing to the PhLOPS A resistance phenotype in Campylobacter.
Genetic environment of cfr(C) gene in Campylobacter
The 48 kb pTx40 plasmid is highly similar to the previously reported plasmids pCC31 (45 kb) and pN29710-1 (55 kb) in C. coli (Figure 2b) . 36, 49 They shared the same conjugative plasmid backbone. Compared with pCC31, pTx40 has an extra 4505 bp segment containing the cfr(C) region, which was inserted between cpp2 and repA by replacing cpp3 and cpp4 (Figure 2c ). The backbone of pTx40 has a GC content of 29.8%, which is close to the GC content of the C. coli chromosome. However, the insertion segment has a GC content of 43.8%, indicating that it was exogenously acquired by Campylobacter. The insertion segment contained six ORFs, and four of them encode antimicrobial resistance determinants including a hygromycin resistance gene (hph), an aphA-3, a truncated streptomycin adenyltransferase (aadE) and the cfr(C) gene (Figure 2c ). The segment, except for the cfr(C) gene, is present in pN29710-1, which contained an additional gene encoding an acetyltransferase and a full-length adenyltransferase encoding region, in contrast to a truncated one in pTx40. Compared with pN29710-1, cfr(C) in pTx40 was inserted downstream of ahpA-3 and replaced two hypothetical genes in pN29710-1 (Figure 2c ).
Distribution of cfr(C) in Campylobacter isolates of bovine origin
To assess the distribution of cfr(C), we conducted PCR analysis of Campylobacter isolates that were collected from 35 different feedlot cattle herds located in five states. Among the 1886 C. jejuni and 344 C. coli isolates examined in this study, 34 C. coli isolates were cfr(C)-mediated multidrug resistance in Campylobacter JAC positive for the cfr(C) gene and they were derived from six different farms in two states (Kansas and Texas). No cfr(C) was found in the examined C. jejuni isolates, indicating the prevalence of cfr(C) is much higher in C. coli isolates (34 of 344, 10.0%) than in C. jejuni isolates (0 of 1886, 0%). All cfr(C)-positive C. coli isolates exhibited chloramphenicol resistance (MIC .16 mg/L) and were subjected to PFGE analysis. All isolates except one showed the same PFGE pattern and shared the same MLST profile ST1068 with Tx40 (PFGE result is partly shown in Figure S1 , available as Supplementary data at JAC Online), suggesting that clonal expansion has been involved in the spread of cfr(C)-positive C. coli in feedlot cattle in the USA.
Discussion
To date, cfr is the only known gene conferring resistance to PhLOPS A antibiotics. 50 Since it was first identified on plasmid pSCFS1 from S. sciuri of bovine origin in 2000, the cfr gene had been found on plasmids in different bacterial species including Bacillus, Enterococcus, Macrococcus, Jeotgalicoccus, Proteus and Escherichia.
3-7 Additionally, the cfr gene has also been reported worldwide, including the USA, China, Germany, Denmark, Italy, Mexico and Ireland. [3] [4] [5] [6] [7] [51] [52] [53] [54] The rapid dissemination of cfr poses a serious threat to antimicrobial therapy because it confers an MDR phenotype. In addition to cfr, a cfr variant, cfr(B), was recently reported in hospital isolates of E. faecium and P. difficile, which is also located on a mobile genetic element and confers a resistance profile similar to that of Cfr. 13, 55 In this study, a novel cfr variant, cfr(C), was discovered in C. coli isolates of cattle origin. It was located on a conjugative plasmid (pTx40) and conferred a multidrug resistance pattern similar to that of the cfr gene. 50, 56 To the best of our knowledge, this is the first report of a cfr-like gene found in foodborne pathogens. The finding of cfr(C) in Campylobacter is alarming because Campylobacter is one of the most common foodborne pathogens. Therefore, cfr(C) may be potentially transferred to humans via the food chain, facilitating the transmission and spread of cfr(C) to other bacterial organisms.
The emergence of cfr(C) in Campylobacter is possibly driven by use of florfenicol in cattle production. Thus, cfr(C) may have facilitated Campylobacter adaptation in the food production environment. Although florfenicol is not used for human medicine, acquisition of cfr(C) results in multidrug resistance. Of particular concern is the fact that it confers resistance to the oxazolidinone class of antibiotics (e.g. linezolid), which is used as the last resort for clinical treatment of MDR bacterial infections in humans. 57 Although linezolid is currently indicated for use in humans for the treatment of Gram-positive bacterial infections and not for campylobacteriosis, the cfr(C) gene in Campylobacter is carried by a conjugative plasmid (pTx40) and may be transferred to other organisms via horizontal gene transfer, posing a potential threat to clinical use of oxazolidinone antibiotics in humans.
It was shown under laboratory conditions that pTx40 was transferable between Campylobacter species by conjugation (Table 1 and Figure 1 ). Although it remains debatable whether conjugative plasmids of Campylobacter can be transferred to other bacterial genera, 58 an early report demonstrated the successful transfer of a tet(O)-carrying plasmid from C. jejuni to E. coli, suggesting that inter-genera dissemination is possible for a conjugative Campylobacter plasmid. 59 Several factors may facilitate the persistence and dissemination of the cfr genes. The use of florfenicol in animal production will continue to serve as a selection pressure for the spread of the cfr genes. As the cfr genes confer an MDR phenotype, the use of other PhLOPS A antibiotics either in animal or human medicine will also facilitate the dissemination of cfr and its variants. Additionally, the cfr genes coexist on mobile vectors with other antibiotic resistance genes that confer resistance to nonPhLOPS A antibiotics [such as tet(O) and aphA-3]. Thus, use of other classes of antibiotics may also promote the prevalence and persistence of cfr-carrying plasmids and mobile elements, further facilitating the dissemination of the MDR mechanism. In pTx40, the 4505 bp segment containing cfr(C) was inserted upstream of repA, where it is considered to be an insertion hotspot and could accommodate different segments. 36 The cfr(C)-carrying segment was not found in other plasmids, but the first five genes of the segment as a whole are present in plasmid pN29710-1 with one hypothetical gene deleted (Figure 2c ). Compared with pCC31 and pN29710-1, the repA gene in pTx40 is 673 bp shorter (Figure 2c ), but the exact form of repA was also found in several other plasmids, such as pcjDM from C. jejuni strain T1-21 (GenBank accession no. CP013117) and pccdm1 from C. coli strain HC2-48 (GenBank accession no. CP013035). The fact that pTx40 can be transferred and maintained in transconjugants indicates that the repA gene is functional. The cfr(C) gene is unique to pTx40 and how the plasmid acquired the gene is unknown. Interestingly, the GC content of the 4505 bp segment is well above that of the rest of the plasmid and that of the C. coli genome, suggesting that pTx40 acquired this insertional fragment exogenously. Detailed analysis of the inserted fragment in pTx40 did not identify insertion sequences or transposable elements. Thus, how cfr(C) was inserted into pTx40 is still unknown. Regardless, given that it is carried by a conjugative plasmid, it is possible that cfr(C) will continue to spread in Campylobacter and beyond.
Cfr homologues are present in both Gram-positive and -negative bacteria, such as Bacillus, Brevibacillus, Clostridium, Paenibacillus, Staphylococcus and E. coli. 50, 51 The proteins of Cfr homologues have similar sizes ranging from 340 to 390 aa. Both Cfr and Cfr(B) were 349 aa long, and mutations have also been reported in Cfr in different bacteria. 3, [5] [6] [7] However, Cfr(C) is significantly different from both Cfr and Cfr(B) (Figure 3 ). It is 30 aa longer and only shares 55% identity with either of them. Interestingly, the N-terminal 352 aa of Cfr(C) are almost identical to the corresponding part of the ribosomal RNA large subunit methyltransferase N from P. difficile ( Figure S2 ). The 64 aa sequence at the C-terminus of the P. difficile methyltransferase was replaced by 27 aa in Cfr(C) in C. coli Tx40 ( Figure S2 ). No homologues of the 27 aa sequence were found in the NCBI database. Therefore, whether the unique 27 aa in Cfr(C) protein forms a functional domain remains to be determined.
At present, cfr(C) is mainly identified in C. coli isolates and the cfr(C)-positive isolates were from different feedlot cattle herds located in two different states. Based on the genotyping results from PFGE and MLST, the majority (33 of 34) of cfr(C)-containing isolates were classified into a single clone, suggesting the possibility of clonal expansion of cfr(C)-positive C. coli in feedlot cattle in the USA. This result also suggests the presence of a selection force (probably use of florfenicol) that has facilitated spread of this cfr(C)-positive clone. Although cfr(C) was not detected in the C. jejuni isolates examined in this study, we demonstrated the Tang et al.
transfer of pTx40 from C. coli to C. jejuni under laboratory conditions. Thus, it is possible that cfr(C) may emerge in C. jejuni, which warrants further surveillance studies to monitor the spread of this MDR determinant in Campylobacter.
In conclusion, this study reports the identification and characterization of a novel plasmid-borne cfr variant, cfr(C) that confers resistance to multiple antibiotics in C. coli. To the best of our knowledge, this represents the first report of a cfr-like gene in a foodborne pathogen. The cfr(C) gene confers a PhLOPS A resistance phenotype similar to that of cfr and is carried on a conjugative plasmid, facilitating its dissemination in Campylobacter and to other bacterial species. The increasing prevalence of cfr(C) in Campylobacter by clonal expression and its potential transmission to humans via the foodborne route highlight its potential threat to public health. Thus, enhanced efforts are needed to monitor and control the spread of cfr(C) in Campylobacter and other bacterial organisms.
